Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations
| Autor: | Katrina Ford, Lisa Peters, Kyle L. Dawson, Tara Miller, A. Cochrane, Reda E. Girgis, Linda J. Stuckey, H. Lyster, Doug Jennings, Michelle M. Kittleson, Phillip Weeks, Stuart D. Russell, T. Tse, Janet Scheel, Maureen Flattery, Monica Colvin, Christina T. Doligalski, Robert L. Page, M. Shullo, Steven Ivulich, Tamara Claridge, Martin Schweiger, C. Yost, Kathleen E. Simpson, JoAnn Lindenfeld, T. Khuu, Christopher R. Ensor, David Weill, Anne I. Dipchand, David A. Baran, Patricia A. Uber |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Graft Rejection
Pulmonary and Respiratory Medicine medicine.medical_specialty Consensus Special populations medicine.medical_treatment 030230 surgery 030226 pharmacology & pharmacy 03 medical and health sciences 0302 clinical medicine Generic drug medicine Drugs Generic Humans Lung transplantation Intensive care medicine Immunosuppression Therapy Heart transplantation Transplantation medicine.diagnostic_test Drug Substitution business.industry Consensus conference Immunosuppression Therapeutic drug monitoring Surgery Cardiology and Cardiovascular Medicine business Immunosuppressive Agents Lung Transplantation |
| Zdroj: | The Journal of Heart and Lung Transplantation. 39:1050-1069 |
| ISSN: | 1053-2498 |
| Popis: | In 2009, the International Society for Heart and Lung Transplantation recognized the importance and challenges surrounding generic drug immunosuppression. As experience with generics has expanded and comfort has increased, substantial issues have arisen since that time with other aspects of immunomodulation that have not been addressed, such as access to medicines, alternative immunosuppression formulations, additional generics, implications on therapeutic drug monitoring, and implications for special populations such as pediatrics and older adults. The aim of this consensus document is to address critically each of these concerns, expand on the challenges and barriers, and provide therapeutic considerations for practitioners who manage patients who need to undergo or have undergone cardiothoracic transplantation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|